Filed in archive
Cases
, Treatment
by Gloria Gamat on April 20, 2007
These were the warning of a recently concluded Cochrane Review.
Dipyrone, a non-opioid painkiller launched in Germany in 1922 was later banned from many countries including the USA and UK because of evidence that it might cause life-threatening blood disorders such as agranulocytosis.
However, dipyrone is a popular analgesic in many parts of the world including South America, India, South Africa, Russia and several European countries. Usually delivered intravenously, oral doses of this drug is available OTC in Brazil and Spain.
According to Dr. Rebecca Gray, a Cochrane Editor who worked closely with the project:
"Given that many effective and more easily administered therapies are available, patients and clinicians will need to consider whether and in what circumstances the benefits of treatment are worth the time, trouble and expense of intravenous administration."
Both physicians and patients should then take note of the potential blood disorder risk of dipyrone.
Read the full report (a pdf file).
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/64723
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for Acute Headache Drug Dipyrone Can Cause Serious Blood Disorders:
|
Rating: 7.00 out of 1 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
